News | Heart Failure | October 13, 2022

Virginia Tech Graduate Student Earns NIH Support to Explore Promising Heart Finding

Grad student in cardiovascular lab at Fralin Biomedical Research Institute will explore a synthetic molecule as basis for a new therapy to treat arrythmias 

Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech.

Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech. 

 


October 13, 2022 —  Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational Biology, Medicine, and Health Graduate Program three years ago. 

But during a trial stint in the lab of Rob Gourdie, a cardiovascular scientist who is a professor and director of the Center for Vascular and Heart Research at the Fralin Biomedical Research Institute at VTC, Williams changed direction. 

While studying a molecule the lab had designed, Williams discovered something new about the way it works. That observation could lead to new ways to treat arrythmias and reduce sudden cardiac death

As a result, Williams has been awarded a two-year, $86,330 grant from the National Institutes of Health’s Ruth L. Kirschstein Predoctoral Individual National Research Service Award program. 

Now his heart is set on advancing cardiovascular discoveries. Williams joined the Gourdie lab full time. 

“Basically, I got hooked and I want to figure this out,” Williams said. “I just really enjoyed learning about heart disease and arrhythmia and the different ways that people have tried to treat those problems in the past and that what I was working on was something that nobody's done before.” 

Williams is studying a specialized adhesion molecule that affects the spaces between heart cells and may contribute to a healthy heart rhythm. Arrythmias contribute to sudden cardiac death, which strikes a half-million people in the United States annually, according to the Centers for Disease Control and Prevention

The molecule, a peptide, was initially conceived and developed by Gourdie, who is also a professor in the Department of Biomedical Engineering and Mechanics in Virginia Tech’s College of Engineering. Peptides are components of proteins. The lab took a section of a protein and recreated it synthetically. 

Previous studies tested the peptide over one hour and found it had negative effects on cell adhesion and heart rhythm. Williams tried something different. He watched it for up to 48 hours and found that over that time period, the peptide had an opposite effect — a result that could potentially improve electrical conduction that affects how the heart beats while reducing arrhythmic incidents. 

With the grant, Williams will test variations of the molecule, over different time periods, to try to identify a combination that could become the basis of a new therapeutic drug. 

“Our ultimate hope,” Williams said, “is to find the right concentration and the right length of treatment to prevent arrhythmias and potentially even sudden cardiac death.” 

For more information: www.vt.edu 


Related Content

News | Sudden Cardiac Arrest

September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...

Home September 09, 2022
Home
News | Sudden Cardiac Arrest

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

Home September 02, 2022
Home
News | Sudden Cardiac Arrest

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

Home September 01, 2022
Home
News | Sudden Cardiac Arrest

August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients ...

Home August 26, 2022
Home
News | Sudden Cardiac Arrest

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

Home July 28, 2022
Home
News | Sudden Cardiac Arrest

July 19, 2022 — Research by GlobalData has highlighted the startling difference between the forecast number of diagnosed ...

Home July 19, 2022
Home
News | Sudden Cardiac Arrest

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...

Home July 13, 2022
Home
News | Sudden Cardiac Arrest

July 11, 2022 — Rod was diagnosed with cancer, but it wasn’t his most urgent medical issue. A few months after that ...

Home July 12, 2022
Home
News | Sudden Cardiac Arrest

June 3, 2022 — Texas Children's Hospital patient Garrett Richardson, 21, is alive today because his quick-thinking ...

Home June 03, 2022
Home
News | Sudden Cardiac Arrest

May 13, 2022 — The MemorialCare Heart & Vascular Institute at Long Beach Medical Center has been designated the only ...

Home May 13, 2022
Home
Subscribe Now